Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression

Athanassios Fragoulis1, Julia Schenkel1, Nicole Schröder1

  • 1Department of Anatomy and Cell Biology, Uniklinik RWTH Aachen, Germany.

Redox Biology
|October 8, 2022
PubMed

Insights

Sustained activation of the Nrf2 pathway drives hepatic stem cell proliferation and dedifferentiation, leading to metastatic cancer. This Nrf2-β-catenin axis promotes liver tumorigenesis.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Hepatology

Background:

  • The Nrf2 signaling pathway is crucial in preventing cancer initiation.
  • However, activating mutations in Nrf2 are prevalent in various cancers, indicating a dual role.
  • The precise mechanisms behind Nrf2's contradictory functions remain unclear.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which sustained Nrf2 activation contributes to cancer development.
  • To investigate the role of Nrf2 in hepatic progenitor cell transformation and tumorigenesis.
  • To identify the specific molecular players involved in Nrf2-driven liver cancer.

Main Methods:

  • Utilized a model of sustained Nrf2 activation in Wnt-responsive hepatic progenitor cells.
  • Analyzed cell proliferation, differentiation status, and metastatic potential.
  • Investigated the expression and activation of β-catenin in response to Nrf2 signaling.

Main Results:

  • Sustained Nrf2 activation induced proliferation and dedifferentiation of hepatic progenitor cells.
  • These transformed cells exhibited characteristics of metastatic cancer and resembled human hepatoblastoma.
  • Nrf2 activation led to increased β-catenin expression and its subsequent activation, driving malignant transformation.

Conclusions:

  • Identified a novel Nrf2-β-catenin signaling axis that promotes hepatic stem cell proliferation and triggers tumorigenesis.
  • Demonstrated that unbridled Nrf2 activation can drive liver cancer initiation and progression.
  • These findings highlight the critical role of Nrf2 levels in maintaining liver homeostasis and preventing oncogenesis.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K